The Swiss RNA Therapeutics Summit brings together stakeholders in the field of RNA Therapeutics from academia, biotechnology, pharma, manufacturing, government, and regulatory bodies with the aim to join forces in this rapidly advancing field. Also, the workshop brings into together companies with potential future employees.
Click on the titles below to see more information on the respective topic.
Origin of the Workshop
The idea of the workshop was born after a panel discussion on “RNA Drugs: Applications Beyond Vaccines” at the Swiss Biotech Day in May 2022 in Basel. The Swiss RNA Therapeutics Summit was for the first edition a joint initiative of the National Center of Competence in Research (NCCR) “RNA & Disease: The Role of RNA in Disease Mechanisms” and the Swiss Biotech Association. Since the second edition, the NCCR RNA & Disease is the organization powering the RNA Therapeutics Summit.
First Swiss RNA Therapeutics Summit – January 2023
The first Swiss RNA Therapeutics Summit took place on Thursday, January 26, 2023, as a full day event at the University of Bern. The first edition was co-organized together with the Swiss Biotech Association.
The event was attended by over 180 persons from industry, academia and other sectors.
The program consisted of opening remarks by Christian Leumann (Rector of the University of Bern and Oligonucleotide Chemistry Expert ), keynotes by Mustafa Diken (Vice President of Vaccines & Immunology, BioNTech) and Shalini Andersson (Vice President Oligonucleotide Discovery, AstraZeneca), panel discussions and company presentations.
We are grateful for the support by all the sponsors and the Oligonucleotide Therapeutics Society and everybody who contributed to the successful event.
Click here to see the program of the 2023 Swiss RNA Therapeutics Summit.
Click here to see the full list of speakers and panelists of the 2023 Swiss RNA Therapeutics Summit.
Click here to see the full list of sponsors of the 2023 Swiss RNA Therapeutics Summit.
Second Swiss RNA Therapeutics Summit – January 2024
The second Swiss RNA Therapeutics Summit took place on January 25, 2024, in Bern and was fully booked with over 200 registered participants. The opening remarks were delivered by the vice-rector research of the University of Bern Hugues Abriel.
The keynotes were given by Paul Nioi (SVP Research Alnylam Pharmaceuticals) on siRNA therapies for neurological diseases and Martin Jinek (Professor University of Zurich and CRISPR co-discoverer) on CRISPR genome editing.
We are grateful for the support by all the sponsors and the Oligonucleotide Therapeutics Society and everybody who contributed to the successful event.
Click here to see the program of the 2024 Swiss RNA Therapeutics Summit.
Click here to see the full list of speakers and panelists of the 2024 Swiss RNA Therapeutics Summit.
Click here to see the full list of sponsors of the 2024 Swiss RNA Therapeutics Summit.